DekaBank Deutsche Girozentrale Sells 20,000 Shares of Teladoc Health, Inc. (NYSE:TDOC)

DekaBank Deutsche Girozentrale lowered its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 22.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,450 shares of the health services provider’s stock after selling 20,000 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Teladoc Health were worth $1,523,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Acadian Asset Management LLC purchased a new position in Teladoc Health in the first quarter worth $27,000. Dark Forest Capital Management LP boosted its position in Teladoc Health by 408.2% in the first quarter. Dark Forest Capital Management LP now owns 1,245 shares of the health services provider’s stock worth $32,000 after purchasing an additional 1,000 shares during the last quarter. Tyler Stone Wealth Management purchased a new position in Teladoc Health in the second quarter worth $33,000. Quarry LP purchased a new position in Teladoc Health in the first quarter worth $35,000. Finally, IFP Advisors Inc boosted its position in Teladoc Health by 201.5% in the second quarter. IFP Advisors Inc now owns 1,969 shares of the health services provider’s stock worth $50,000 after purchasing an additional 1,316 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

TDOC has been the topic of several research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Friday, April 5th. Piper Sandler dropped their price target on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 21st. Royal Bank of Canada dropped their price target on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 21st. Truist Financial dropped their price target on Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Finally, Barclays dropped their price target on Teladoc Health from $26.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 21st. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $22.23.

Insiders Place Their Bets

In other news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the transaction, the insider now owns 57,223 shares in the company, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders have sold 134,441 shares of company stock worth $2,025,041 in the last ninety days. 1.63% of the stock is currently owned by insiders.

Teladoc Health Stock Down 2.7 %

Shares of NYSE TDOC opened at $14.21 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The stock’s 50-day simple moving average is $16.27 and its two-hundred day simple moving average is $18.09. Teladoc Health, Inc. has a twelve month low of $13.59 and a twelve month high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. The business had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.23) EPS. On average, analysts predict that Teladoc Health, Inc. will post -1.07 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.